AQW-051 50 mg | ≥95% Cayman Chemical A partial agonist of a7 nAChR More Information Supplier Page × AQW-051
AQW-051 5 mg | ≥95% Cayman Chemical A partial agonist of a7 nAChR More Information Supplier Page × AQW-051
AQW-051 25 mg | ≥95% Cayman Chemical A partial agonist of a7 nAChR More Information Supplier Page × AQW-051
AQW-051 10 mg | ≥95% Cayman Chemical A partial agonist of a7 nAChR More Information Supplier Page × AQW-051
Palazestrant 500 µg | ≥98% Cayman Chemical An ERa antagonist More Information Supplier Page × Palazestrant
Palazestrant 5 mg | ≥98% Cayman Chemical An ERa antagonist More Information Supplier Page × Palazestrant
Palazestrant 1 mg | ≥98% Cayman Chemical An ERa antagonist More Information Supplier Page × Palazestrant
PF-06835919 5 mg | ≥98% Cayman Chemical A KHK-C inhibitor More Information Supplier Page × PF-06835919
PF-06835919 25 mg | ≥98% Cayman Chemical A KHK-C inhibitor More Information Supplier Page × PF-06835919
PF-06835919 10 mg | ≥98% Cayman Chemical A KHK-C inhibitor More Information Supplier Page × PF-06835919
